The microarray analysis indicated that FGF8 was up regulated by 8.31-fold in prostate cancer tissues compared to BPH tissue which was further confirmed by western blot analysis (2.56 fold over-expressed in cancer tissues, p = 0.001) and immunohistochemistry in the study samples (Fig. 6a and b). This evidence concerns the gene FGF8 and prostate carcinoma.